Sunway Bhd (5211) – Healthcare re-rating [$$bill]

Sunway Bhd (5211) – Healthcare re-rating


Sunway could see some upside if research houses start raising the valuation of its healthcare business.


Bloomberg reported today that Sunway is looking to sell a 20-25% stake in its healthcare unit that could fetch at least USD250 mil.


That means:

If a 20% stake is worth USD250 mil, 100% stake is worth USD1.25 bil.

If a 25% stake is worth USD250 mil, 100% stake is worth USD1 bil.


USD1 bil is about RM4.15 bil.


That is much higher than the valuations given by some research houses, such as:


Kenanga IB: RM1,788 mil

Hong Leong IB: RM1,734 mil

Affin Hwang IB: RM1,800 mil

UOB Kay Hian: RM1,250 mil


(See pics at bottom)


Among the four above, Affin Hwang gave the highest valuation of RM1.8 bil.


However, using that USD1 bil (RM4.15 bil) valuation, that’s still a surplus of RM2.35 bil or 42 sen per share (based on fully diluted no. of shares).


42 sen is equivalent to 30% of Sunway’s share price of RM1.40.


The research houses are valuing using the price-to-earnings method. If valued based on the number of hospital beds, Sunway’s heathcare business should fetch a higher valuation (read: https://www.theedgemarkets.com/article/unlocking-value-healthcare-business)


From research reports dated 26 Aug 2020:






Join my Telegram channel for random updates @worthystocks 

https://t.me/worthystocks



#SUNWAY






Comments

Popular posts from this blog

Focus Point (0157) – A strong recovery stock riding on the success of FamilyMart and MORE [$$bill]

SARAWAK PLANTATION (SWKPLNT) – a horse with latent potential + the right jockey = a CHAMPION racehorse

The SUPERNOVA of STAR MEDIA (6084): A Burst of Earnings?